We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mr
David
Russell
-
davidrussell1@nhs.net
More information about this study, what is involved and how to take part can be found on the study website.
Osteomyelitis in diabetes with foot ulcer
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Diabetes affects 4.5 million adults in the UK, a quarter of whom will develop a diabetic foot ulcer (foot wound; DFU). One in five people with a DFU will develop ‘high-risk characteristics’ of infection in the bone underlying the wound (osteomyelitis; DFO). The treatment for this is usually 6 weeks of antibiotics, but in some it needs an operation to remove the infected bone, often with a toe or foot amputation. There is no “gold-standard” diagnostic test and current diagnostic strategies may over-diagnose DFO in up to one-third of people, meaning an unnecessary prolonged course of antibiotics.
This study aims to answer three questions to improve the diagnosis of DFO:
1. What is the current clinical standard for diagnosis of DFO?
2. Which of the two bone sampling methods gives the best results for the diagnosis of DFO?
3. Can we better diagnose DFO using a combination of wound appearance, blood tests and X-ray?
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
No exclusion criteria for full clinical cohort or phase 1 and 3 high-risk cohorts (as advised by PPI members).
High-risk phase 2 diagnostic concordance study cohort:1. Unable to undergo both ‘through-the-ulcer’ and ‘remote’ bone biopsies2. Would not be ethically appropriate to approach the patient e.g. on end of life care
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Mr
David
Russell
-
davidrussell1@nhs.net
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Leeds and funded by NIHR Academy; Grant Codes: NIHR300633.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 49009
You can print or share the study information with your GP/healthcare provider or contact the research team directly.